Equal rates of drug resistance in leprosy cases with relapse and recurrent/chronic Type 2 reaction: time to revise the guidelines for drug‐resistance testing in leprosy?

Author:

Narang T.1ORCID,Kamat D.1ORCID,Thakur V.1ORCID,Lavania M.2,Singh I.3,Ahuja M.3,Dogra S.1ORCID

Affiliation:

1. Department of Dermatology, Venereology and Leprology Postgraduate Institute of Medical Education and Research Chandigarh India

2. Enteric Viruses Group ICMR‐National Institute of Virology Pune India

3. Department of Molecular Biology Stanley Browne Laboratory TLM Community Hospital New Delhi India

Publisher

Wiley

Subject

Dermatology

Reference19 articles.

1. Global leprosy update, 2018: moving towards a leprosy‐free world [Situation de la lèpre dans le monde, 2018: parvenir à un monde exempt de lèpre];World Health Organization/Organisation mondiale de la Santé;Wkly Epidemiol Rec, Releve epidemiol hebd,2019

2. RIFAMPIN-RESISTANT LEPROSY

3. Antimicrobial resistance in leprosy: results of the first prospective open survey conducted by a WHO surveillance network for the period 2009–15

4. Drug resistance patterns in Mycobacterium leprae isolates from relapsed leprosy patients attending The Leprosy Mission (TLM) Hospitals in India

Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3